Ukrainian-born, London-based designer known for her experimental, deconstructed denim and subversive Y2K-inspired style.
ORIGIN
Ukraine
PRICE TIER
contemporary
SPECIALIZATION
WOMEN
Launched in 2021 by the Ukrainian-born, London-based designer, Masha Popova’s eponymous label is celebrated for its experimental and subversive approach to womenswear. A graduate of Central Saint Martins with experience at Maison Margiela and Celine, Popova channels her post-Soviet childhood and architectural background into her designs. The brand is best known for its innovative work with denim, using techniques like bleaching, deconstruction, and digital embroidery to create signature pieces like low-slung jeans, asymmetrical jackets, and iconic butterfly-motif tops. Her work merges a raw, carefree attitude with a high-fashion sensibility, resulting in what she calls "decadent sportswear with irreverent elegance."
$329.50$659.00
$309.50$619.00
$329.50$659.00
$309.50$619.00

In this direct Q&A, Masha Popova discusses her Ukrainian heritage, her design philosophy centered on transformation and denim, and pivotal moments that have shaped her as a designer, providing core insight into her vision.

This interview focuses on the collaboration between Masha Popova and musician PinkPantheress for the brand's Fall/Winter 2024 campaign, exploring the inspiration and creative process behind the partnership.

A review of the Fall 2025 collection, which is described as Popova's most autobiographical to date. It explores themes of comfort, movement, and the beauty of imperfection, drawing inspiration from artist Sophie Calle.

This article details a creative shift for the brand towards a more 'sophisticated' and 'adult' aesthetic for Spring 2025, while still exploring deconstruction. It also notes a one-off customization project with Adidas.

This review of the Fall 2024 collection explores Popova's ironic take on luxury, inspired by 'Generation Wealth' and MTV Cribs. It also mentions a collaboration with denim producer ISKO to create unique fabric treatments.